Changlin Li

Tianjin, 300211, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Alternol-Induced Oxidative Modification of SQSTM1/p62 Is Associated with Nrf2 Signaling and Autophagy-Related Responses in Prostate Cancer Cells.

Alternol-Induced Oxidative Modification of SQSTM1/p62 Is Associated with Nrf2 Signaling and Autophagy-Related Responses in Prostate Cancer Cells.

Journal: Antioxidants (Basel, Switzerland)

Published: April 27, 2026

SSTDhunter: a curated gene database for investigating androgen producing potential in microbiota species.

SSTDhunter: a curated gene database for investigating androgen producing potential in microbiota species.

Journal: Frontiers in cellular and infection microbiology

Published: November 26, 2025

MIF Facilitates Resistance to Androgen Deprivation Therapy by Regulating AMPD2 Expression in Prostate Cancer Cells.

MIF Facilitates Resistance to Androgen Deprivation Therapy by Regulating AMPD2 Expression in Prostate Cancer Cells.

Journal: The Prostate

Published: July 24, 2025

Mesenchymal Stem Cells Senescence: Mechanism and Rejuvenation Interventions.

Mesenchymal Stem Cells Senescence: Mechanism and Rejuvenation Interventions.

Journal: International journal of medical sciences

Published: April 13, 2025

Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death.

Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death.

Journal: Frontiers in pharmacology

Published: March 06, 2024

Respiratory pathogenic microbial infections: a narrative review.

Respiratory pathogenic microbial infections: a narrative review.

Journal: International journal of medical sciences

Published: December 26, 2023

Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages.

Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages.

Journal: International journal of medical sciences

Published: September 21, 2022

Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein.

Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein.

Journal: Cell death & disease

Published: May 05, 2022

Showing 1-8 of 8

Last Updated: 09/26/2026